Bioethics News

Gels to Repair Hearing Loss? Drugmakers Try New Ear Treatments

October 17, 2016

(Bloomberg) – Drugmakers are jumping in to offer innovative treatments like gels and gene therapy to prevent or even reverse tinnitus and hearing loss — which affect 25 million and 48 million people in the U.S., respectively. Undeterred by recent setbacks in clinical trials, some pharmaceutical companies see hearing-loss drugs turning into a multi-billion dollar market, bolstered by the stigma associated with wearing hearing aids and exposure to loud music through headphones in younger generations.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.